ACOG - Alpha Cognition Income before deduction of interest, taxes and amortization
Alpha Cognition relies on a North American base for the development of Alzheimer's therapies. A strategic alliance with dementia centers is accelerating the market launch of Zunveyl, while preparations for the commercial release are expanding neurological research. The underlying EBITDA confirms the issuer's financial stability, with the current parameter equal to 0.00.
Summary analytical data breakdowns for Alpha Cognition Inc. (ACOG)
- share price and consensus valuation forecast:
- market capitalization statistics:
- book capitalization information:
- business debt structure and liquidity details:
Total Debt to Equity Ratio Alpha Cognition|ACOG - Long-Term Debt to Equity|Current Liabilities to Capital Alpha Cognition Inc|ACOG - Company Aggregate Debts|Debt to Net Assets Alpha Cognition|ACOG - Company Long-Term Debt|Company Short-Term Indebtedness Alpha Cognition|Interim Coverage Ratio alphacognition.com
- business earnings and investment ratios data:
ACOG - Net Income|Future Net Profit Alpha Cognition|ACOG - P/E Multiple|Market Cap to Projected Earnings Alpha Cognition Inc|ACOG - Price/Earnings to Growth Ratio|Company Value to EBITDA Alpha Cognition|ACOG - Profit before payment of interest, taxes and amortization|Earnings per share for the last 12 months Alpha Cognition|ACOG - Net earnings per share (EPS TTM)|Quarterly EPS earnings growth alphacognition.com|ACOG - Earnings growth in current year|Expected earnings per share growth for next year Alpha Cognition
Summary company analytics:ACOG, Alpha Cognition
Alpha Cognition expenditures on promoting its Alzheimer's drug are creating a temporary liquidity deficit, making the monitoring of net cash receipts from sales before interest and taxes critical. The current value of 0.00 allows for a real-time assessment of operational efficiency, while sharp spikes in operating cash flow before interest and taxes may signal an asset overvaluation.
Competitors of Alpha Cognition (ACOG)
BIIB (Biogen Idec) - Profit before deduction of interest, taxes, depreciation and amortization|Neurocrine Biosciences - Operating profit EBITDA|Income before deduction of interest, taxes and amortization RGC (regencellbioscience.com)|AXSM: Operating profit EBITDA|ACADIA Pharma (ACAD) - Operating profit EBITDA|Operating profit before deduction of amortization XENE|VKTX: Income before deduction of interest, taxes and amortization|Operating profit EBITDA SUPN|Operating profit before deduction of amortization catalystpharma.com CPRX|Profit before payment of interest, taxes and amortization Denali Therapeutics Inc. DNLI|Harmony Biosciences Inc (HRMY) - Profit before interest, taxes and amortization|Biohaven Pharmaceutical - Operating profit EBITDA|Operating profit before depreciation charges Amylyx Corp (AMLX)|Trevi Therapeutics (TRVI) - Profit before payment of interest, taxes and amortization|Operating profit before amortization PRAX|AVXL (Anavex Life Sciences Corp.) - Operating profit EBITDA|CeriBell Inc (CBLL) - Operating income before deduction of amortization|Operating profit before deduction of amortization PRTA (Prothena Corp)|Company profit before taxes, interest and amortization ALEC|Operating profit EBITDA ANNX (Annexon, Inc.)|Operating income before deduction of amortization Omeros Corp (OMER)|NGNE - Profit before payment of interest, taxes and amortization|Profit before interest, taxes and amortization AC Immune S.A.|Voyager Pharma (VYGR) - Profit before payment of interest, taxes and amortization|Operating profit before amortization NMRA|SCLX (Scilex Holding Company) - Operating profit EBITDA|Operating profit EBITDA tevogen.com|Operating profit EBITDA CGTX|Operating profit before deduction of amortization Inhibikase Therapeutics Inc IKT|Profit before payment of interest, taxes and amortization Cassava SAVA|Assertio Holdings (ASRT) - Profit before interest, taxes and amortization|Coya - Operating profit EBITDA|Operating profit before depreciation charges Vistagen Therapeutics (VTGN)|ovidrx.com (OVID) - Profit before payment of interest, taxes and amortization|Operating profit before amortization ABOS|CRVO (CervoMed Inc) - Operating profit EBITDA|Profit before interest, taxes and amortization Alterity Therapeutics Ltd ATHE|Operating profit before deduction of amortization CLNN (Clene Inc.)|Operating profit EBITDA pepgen.com (PEPG)|Profit before payment of interest, taxes and amortization Jupiter Neurosciences JUNS|Income before deduction of interest, taxes and amortization RLMD|ANVS - Profit before payment of interest, taxes and amortization|Profit before interest, taxes and amortization Grace Therapeutics, Inc.|AIFF: Operating profit EBITDA|Klotho Neurosciences (KLTO) - Operating profit EBITDA|Profit before payment of interest, taxes and amortization NeuroSense Therapeutics Ltd|Profit before payment of interest, taxes and amortization RVPH|Profit before payment of interest, taxes and amortization MetaVia Inc (MTVA)|NRXS: Profit before deduction of interest, taxes, depreciation and amortization|Operating profit EBITDA HSDT (Helius Medical Technologies)|Income before deduction of interest, taxes and amortization PASG|Neuphoria - Operating profit EBITDA|NERV - Operating profit EBITDA|ATHA (Athira) - Operating profit before deduction of amortization|Addex - Income before deduction of interest, taxes and amortization|ALZN (Alzamend Neuro Inc.) - Operating profit EBITDA|Operating profit before deduction of amortization Cyclerion (CYCN)|Profit before payment of interest, taxes and amortization Protagenic Therapeutics (PTIX)|KTTA - Profit before interest, taxes and amortization|Operating profit EBITDA CRGT (Cortigent)|Operating profit before depreciation charges Avenue Therapeutics Inc|BCLI - Profit before payment of interest, taxes and amortization|CARA (caratherapeutics.com) - Operating profit before amortization|CHRO: Operating profit EBITDA|ELYM - Operating income before deduction of amortization|Operating profit before deduction of amortization ITCI|LBPH (Longboard) - Company profit before taxes, interest and amortization|Operating profit EBITDA MRNS|Operating income before deduction of amortization nkgenbiotech.com|Profit before payment of interest, taxes and amortization NeuroBo Pharmaceuticals, Inc. NRBO|Sage Therapeutics Inc. (SAGE) - Profit before interest, taxes and amortization|SNPX - Profit before payment of interest, taxes and amortization|TRVN (Trevena Inc) - Operating profit before amortization|VIGL: Operating profit EBITDA|anewmeds.com (WENA) - Operating profit EBITDA|CERE (Cerevel Therapeutics, Inc.) - Operating profit EBITDA
